Patents by Inventor Jean-Claude Dussaule

Jean-Claude Dussaule has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for preventing and treating chronic kidney disease (CKD)
    Patent number: 9926562
    Abstract: The present invention relates to methods for preventing and treating chronic kidney disease (CKD).
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: March 27, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), ASSITANCE PUBLIQUE—HOPITAUX DE PARIS, INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
    Inventors: Christos Chatziantoniou, Jean-Claude Dussaule, Simon J. Conway
  • A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION
    Publication number: 20170160290
    Abstract: The invention relates to a method for determining whether a renal transplanted patient is at risk of transplant rejection or CAN, comprising a step of determining the expression level of the periostin (POSTN) gene on a renal transplant biopsy obtained from said transplanted patient. The invention also relates to a compound selected from the group consisting of monoclonal anti-CD20 antibodies, anti-thymocyte globulin, proteasome inhibitors, anti-C antibodies, monoclonal anti-CD3 antibodies, glucocorticoids, cytostatics, calcineurin inhibitors and mTOR inhibitors, for use in a method for preventing renal transplant rejection and in CAN development in a transplanted patient determined as being at risk of renal transplant rejection according to a method of the invention.
    Type: Application
    Filed: July 8, 2015
    Publication date: June 8, 2017
    Inventors: Christos CHATZIANTONIOU, Jean-Claude DUSSAULE, Piergiorgio MESSA, Carlo ALFIERI
  • METHODS FOR PREVENTING AND TREATING CHRONIC KIDNEY DISEASE (CKD)
    Publication number: 20170067053
    Abstract: The present invention relates to methods for preventing and treating chronic kidney disease (CKD).
    Type: Application
    Filed: November 17, 2016
    Publication date: March 9, 2017
    Inventors: Christos CHATZIANTONIOU, Jean-Claude DUSSAULE, Simon J. CONWAY
  • DDR1 ANTAGONIST OR AN INHIBITOR OF DDR1 GENE EXPRESSION FOR USE IN THE PREVENTION OR TREATMENT OF CRESCENTIC GLOMERULONEPHRITIS
    Publication number: 20160304881
    Abstract: The present invention relates to uses, methods and compositions for treating crescentic glomerulonephritis. More specifically, the present invention relates to a DDR1 antagonist or an inhibitor of DDR1 gene expression for the prevention or the treatment of said disease.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 20, 2016
    Inventors: Christos CHATZIANTONIOU, Jean-Claude DUSSAULE
  • DDR1 ANTAGONIST OR AN INHIBITOR OF DDR1 GENE EXPRESSION FOR USE IN THE PREVENTION OR TREATMENT OF CRESCENTIC GLOMERULONEPHRITIS
    Publication number: 20140286965
    Abstract: The present invention relates to uses, methods and compositions for treating crescentic glomerulonephritis. More specifically, the present invention relates to a DDR1 antagonist or an inhibitor of DDR1 gene expression for the prevention or the treatment of said disease.
    Type: Application
    Filed: November 6, 2012
    Publication date: September 25, 2014
    Applicant: INSERM
    Inventors: Christos Chatziantoniou, Jean-Claude Dussaule
  • METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF HAVING OR DEVELOPING A CHRONIC KIDNEY DISEASE
    Publication number: 20140080128
    Abstract: The invention relates to a method for determining whether a subject is at risk of having or developing a chronic kidney disease (CKD) comprising determining the expression level of the periostin gene in a biological sample obtained from said subject. The invention also relates to a method for staging a CKD in a patient comprising determining the expression level of the periostin gene in a biological sample obtained from said patient. The invention further relates to a method for determining the responsiveness of a patient suffering from a CKD to a treatment comprising determining the expression level of the periostin gene in a biological sample obtained from said patient.
    Type: Application
    Filed: May 18, 2012
    Publication date: March 20, 2014
    Applicant: Institut National de Ia Sante et de la Recherche Medicale (INSERM)
    Inventors: Christos Chatziantoniou, Sandrine Placier, Jean-Claude Dussaule